Ali Toumadj Email

VP, Head Medical Sciences . Vigil Neuroscience

Current Roles

Employees:
80
Revenue:
$7.6M
About
Vigil Neuroscience is the world's first microglia-focused therapeutics company. Our purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain's immune system. We are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and their families.
Vigil Neuroscience Address
100 Forge Road
Cambridge, MA
United States
Vigil Neuroscience Email

Past Companies

Vigil NeuroscienceVice President, Head of Medical Sciences
Alnylam PharmaceuticalsSr. Medical Director
Alnylam PharmaceuticalsSr. Director, Medical Affairs at Alnylam Pharmaceuticals

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.